Treponema pallidum subsp. pallidum with an Artificially impaired TprK antigenic variation system is attenuated in the Rabbit model of syphilis

BACKGROUND The TprK protein of the syphilis agent, Treponema pallidum subsp. pallidum (T. pallidum), undergoes antigenic variation in seven discrete variable (V) regions via non-reciprocal segmental gene conversion. These recombination events transfer information from a repertoire of 53 silent chromosomal donor cassettes (DCs) into the single tprK expression site to continually generate TprK variants. Several lines of research developed over the last two decades support the theory that this mechanism is central to T. pallidum's ability for immune avoidance and persistence in the host. Structural and modeling data, for example, identify TprK as an integral outer membrane porin with the V regions exposed on the pathogen's surface. Furthermore, infection-induced antibodies preferentially target the V regions rather than the predicted β-barrel scaffolding, and sequence variation abrogates the binding of antibodies elicited by antigenically different V regions. Here, we engineered a T. pallidum strain to impair its ability to vary TprK and assessed its virulence in the rabbit model of syphilis. PRINCIPAL FINDINGS A suicide vector was transformed into the wild-type (WT) SS14 T. pallidum isolate to eliminate 96% of its tprK DCs. The resulting SS14-DCKO strain exhibited an in vitro growth rate identical to the untransformed strain, supporting that the elimination of the DCs did not affect strain viability in absence of immune pressure. In rabbits injected intradermally with the SS14-DCKO strain, generation of new TprK sequences was impaired, and the animals developed attenuated lesions with a significantly reduced treponemal burden compared to control animals. During infection, clearance of V region variants originally in the inoculum mirrored the generation of antibodies to these variants, although no new variants were generated in the SS14-DCKO strain to overcome immune pressure. Naïve rabbits that received lymph node extracts from animals infected with the SS14-DCKO strain remained uninfected. CONCLUSION These data further support the critical role of TprK in T. pallidum virulence and persistence during infection.

[1]  S. Ovchinnikov,et al.  ColabFold: making protein folding accessible to all , 2022, Nature Methods.

[2]  Kelika A. Konda,et al.  Treponema pallidum genome sequencing from six continents reveals variability in vaccine candidate genes and dominance of Nichols clade strains in Madagascar , 2021, PLoS neglected tropical diseases.

[3]  B. Molini,et al.  Longitudinal TprK profiling of in vivo and in vitro-propagated Treponema pallidum subsp. pallidum reveals accumulation of antigenic variants in absence of immune pressure , 2021, PLoS neglected tropical diseases.

[4]  Bing Zhang,et al.  Full-length TprK of Treponema pallidum subsp. pallidum in lipid nanodiscs is a monomeric porin. , 2021, Enzyme and microbial technology.

[5]  Oriol Vinyals,et al.  Highly accurate protein structure prediction with AlphaFold , 2021, Nature.

[6]  Q. Phung,et al.  Genetic engineering of Treponema pallidum subsp. pallidum, the Syphilis Spirochete , 2021, bioRxiv.

[7]  A. Addetia,et al.  Estimation of Full-Length TprK Diversity in Treponema pallidum subsp. pallidum , 2020, mBio.

[8]  Robert D. Finn,et al.  MGnify: the microbiome analysis resource in 2020 , 2019, Nucleic Acids Res..

[9]  C. Marra,et al.  Comparative genomics and full-length Tprk profiling of Treponema pallidum subsp. pallidum reinfection , 2019, bioRxiv.

[10]  S. Norris,et al.  Long-Term In Vitro Culture of the Syphilis Spirochete Treponema pallidum subsp. pallidum , 2018, mBio.

[11]  Johannes Söding,et al.  MMseqs2: sensitive protein sequence searching for the analysis of massive data sets , 2017, bioRxiv.

[12]  Chengxin Zhang,et al.  PyMod 2.0: improvements in protein sequence‐structure analysis and homology modeling within PyMOL , 2016, Bioinform..

[13]  Man-li Tong,et al.  Re-evaluating the sensitivity of the rabbit infectivity test for Treponema pallidum in modern era. , 2017, Clinica chimica acta; international journal of clinical chemistry.

[14]  J. Krause,et al.  Origin of modern syphilis and emergence of a pandemic Treponema pallidum cluster , 2016, Nature Microbiology.

[15]  R. Rochat,et al.  Global burden of maternal and congenital syphilis in 2008 and 2012: a health systems modelling study , 2016, The Lancet. Global health.

[16]  L. Giacani,et al.  Treponema pallidum Lipoprotein TP0435 Expressed in Borrelia burgdorferi Produces Multiple Surface/Periplasmic Isoforms and mediates Adherence , 2016, Scientific Reports.

[17]  James F. Smith,et al.  The continuing threat of syphilis in pregnancy , 2016, Current opinion in obstetrics & gynecology.

[18]  Peter B. McGarvey,et al.  UniRef clusters: a comprehensive and scalable alternative for improving sequence similarity searches , 2014, Bioinform..

[19]  B. Molini,et al.  Antigenic Variation of TprK Facilitates Development of Secondary Syphilis , 2014, Infection and Immunity.

[20]  B. Molini,et al.  Complete Genome Sequence of the Treponema pallidum subsp. pallidum Sea81-4 Strain , 2014, Genome Announcements.

[21]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[22]  C. Ison,et al.  Rapid increase in gonorrhoea and syphilis diagnoses in England in 2011. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[23]  B. Molini,et al.  Comparative Investigation of the Genomic Regions Involved in Antigenic Variation of the TprK Antigen among Treponemal Species, Subspecies, and Strains , 2012, Journal of bacteriology.

[24]  Shane S. Sturrock,et al.  Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data , 2012, Bioinform..

[25]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[26]  Myron S. Cohen,et al.  China's syphilis epidemic: epidemiology, proximate determinants of spread, and control responses , 2011, Current opinion in infectious diseases.

[27]  B. Molini,et al.  Antigenic Variation in Treponema pallidum: TprK Sequence Diversity Accumulates in Response to Immune Pressure during Experimental Syphilis , 2010, The Journal of Immunology.

[28]  C. Lowndes,et al.  Syphilis and gonorrhoea in men who have sex with men: a European overview. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[29]  H. Kuramitsu,et al.  Heterologous Expression of the Treponema pallidum Laminin-Binding Adhesin Tp0751 in the Culturable Spirochete Treponema phagedenis , 2008, Journal of bacteriology.

[30]  C. D. Da Ros,et al.  Global epidemiology of sexually transmitted diseases. , 2008, Asian journal of andrology.

[31]  C. Marra,et al.  Isolation and Laboratory Maintenance of Treponema pallidum , 2007, Current protocols in microbiology.

[32]  B. Molini,et al.  Quantitative Analysis of tpr Gene Expression in Treponema pallidum Isolates: Differences among Isolates and Correlation with T-Cell Responsiveness in Experimental Syphilis , 2006, Infection and Immunity.

[33]  B. Molini,et al.  Antigenic Variation of TprK V Regions Abrogates Specific Antibody Binding in Syphilis , 2006, Infection and Immunity.

[34]  W. V. Van Voorhis,et al.  TprK Sequence Diversity Accumulates during Infection of Rabbits with Treponema pallidum subsp. pallidum Nichols Strain , 2006, Infection and Immunity.

[35]  S. Lukehart,et al.  Biological Basis for Syphilis , 2006, Clinical Microbiology Reviews.

[36]  L. Giacani,et al.  Gene Organization and Transcriptional Analysis of the tprJ, tprI, tprG, and tprF Loci in Treponema pallidum Strains Nichols and Sea 81-4 , 2005, Journal of bacteriology.

[37]  J. Kaldor,et al.  Epidemic syphilis among homosexually active men in Sydney , 2005, The Medical journal of Australia.

[38]  K. Turner,et al.  The Re-Emergence of Syphilis in the United Kingdom: The New Epidemic Phases , 2005, Sexually transmitted diseases.

[39]  B. Molini,et al.  Gene conversion: a mechanism for generation of heterogeneity in the tprK gene of Treponema pallidum during infection , 2004, Molecular microbiology.

[40]  W. V. Van Voorhis,et al.  Sequence Diversity of Treponema pallidum subsp. pallidum tprK in Human Syphilis Lesions and Rabbit-Propagated Isolates , 2003, Journal of bacteriology.

[41]  R. Goldenberg,et al.  The infectious origins of stillbirth. , 2003, American journal of obstetrics and gynecology.

[42]  B. Molini,et al.  Segregation of B and T Cell Epitopes of Treponema pallidum Repeat Protein K to Variable and Conserved Regions During Experimental Syphilis Infection1 , 2002, The Journal of Immunology.

[43]  Tetsuya Hayashi,et al.  Complete Nucleotide Sequence of Plasmid Rts1: Implications for Evolution of Large Plasmid Genomes , 2002, Journal of bacteriology.

[44]  D. L. Cox,et al.  The Tprk Protein of Treponema pallidum Is Periplasmic and Is Not a Target of Opsonic Antibody or Protective Immunity , 2001, The Journal of experimental medicine.

[45]  L. Stamm,et al.  The Sequence-Variable, Single-Copy tprKGene of Treponema pallidum Nichols Strain UNC and Street Strain 14 Encodes Heterogeneous TprK Proteins , 2000, Infection and Immunity.

[46]  W. V. Van Voorhis,et al.  The tprK Gene Is Heterogeneous amongTreponema pallidum Strains and Has Multiple Alleles , 2000, Infection and Immunity.

[47]  H. Kuramitsu,et al.  Development of a System for Expressing Heterologous Genes in the Oral Spirochete Treponema denticola and Its Use in Expression of the Treponema pallidum flaA Gene , 1999, Infection and Immunity.

[48]  V. Tapson Syphilis , 1887, The Lancet.

[49]  M. Norgard,et al.  Analysis of the N-terminal region of the 47-kilodalton integral membrane lipoprotein of Treponema pallidum , 1992, Infection and immunity.

[50]  S. Lukehart,et al.  Development of cellular immunity to individual soluble antigens of Treponema pallidum during experimental syphilis. , 1988, Journal of immunology.

[51]  S Falkow,et al.  Molecular Koch's postulates applied to microbial pathogenicity. , 1988, Reviews of infectious diseases.

[52]  M. Janier Ceftriaxone is effective for treating patients with primary syphilis. , 1988, Sexually Transmitted Diseases.

[53]  P. Hardy,et al.  Infectivity tests in syphilis. , 1969, The British journal of venereal diseases.